News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
|Articles|October 15, 2009

Listen to a preview of Drugs, Devices or Data - Which is Most Valuable? Webcast

Advertisement

Listen to a preview of Drugs, Devices or Data – Which is Most Valuable? Webcast

Download Adobe Flash PlayerRegister Free for the Webcast

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement
Technology

Related Content

Advertisement
Drug labeling is a distinct linguistic domain, and models not trained explicitly on it struggle with it. Credit: Stock.Adobe.com/GamePixel.

How AI Is Transforming Drug Labeling

ByPartha Anbil,Partha Khot ,Prashant Deshpande
April 16th 2026
Jane Li, Thermo Fisher

Bridging the Precision Gap: Accelerating Clinical Adoption of Companion Diagnostics in Oncology

ByJane Li
April 8th 2026
Stock.adobe.com

How Agentic AI Is Reshaping the Launch Playbook for Pharma

ByNatalie Harb,Vineet Purwar
April 7th 2026
Generative AI is transitioning from experimental use to real-world healthcare applications, highlighting its impact on diagnostics, operations, and drug discovery alongside the challenges of ensuring accuracy, reliability, and regulatory compliance. Credit: Stock.Adobe.com/Naret

Advancing Healthcare with Generative AI: From Promise to Practice

ByPartha Anbil,Niraj Patel
April 6th 2026

Scaling AI's Promise in Healthcare: The Time is Now

ByMichael Christel,Pratap Khedkar, PhD
April 3rd 2026
Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics

2

President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs

3

Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff

4

Addressing Regulatory Issues and the Biosimilar Void: Q&A with Thomas Newcomer

5

Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us